Browse by People

Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.

Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Fowotade, Adeola, Olagunoye, Ajibola, Ojo, Temitope Olumuyiwa, Adefuye, Bolanle Olufunlola, Fagbamigbe, Adeniyi Francis, Adebiyi, Akindele Olupelumi, Olagunju, Omobolanle Ibitayo, Ladipo, Olabode Taiwo, Akinloye, Abdulafeez
et al (show 6 more authors) (2021) Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial. Trials, 22 (1).

Shenkoya, Babajide, Atoyebi, Shakir ORCID: 0000-0002-1393-3753, Eniayewu, Ibrahim, Akinloye, Abdulafeez and Olagunju, Adeniyi ORCID: 0000-0002-6588-5749
(2021) Mechanistic Modeling of Maternal Lymphoid and Fetal Plasma Antiretroviral Exposure During the Third Trimester. FRONTIERS IN PEDIATRICS, 9.

Akinloye, Abdulafeez, Eniayewu, Oluwasegun, Adeagbo, Babatunde, Bolaji, Oluseye and Olagunju, Adeniyi ORCID: 0000-0002-6588-5749
(2022) Validation and Clinical Application of a Liquid Chromatography-Ultraviolet Detection Method to Quantify Dolutegravir in Dried Blood Spots. THERAPEUTIC DRUG MONITORING, 44 (3). 430 - 437.

Fowotade, Adeola, Bamidele, Folasade, Egbetola, Boluwatife, Fagbamigbe, Adeniyi F, Adeagbo, Babatunde A, Adefuye, Bolanle O, Olagunoye, Ajibola, Ojo, Temitope O, Adebiyi, Akindele O, Olagunju, Omobolanle I
et al (show 8 more authors) (2022) A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19. Frontiers in Medicine, 9.

This list was generated on Wed Oct 19 04:31:51 2022 BST.